Peter Heudtlass


AuthID: R-00H-Q6C

Publicações a aguardarem confirmação

1
TITLE: Cetuximab versus bevacizumab in metastatic colorectal cancer: a comparative effectiveness study  Full Text
AUTHORS: Rui Pedro Marques; Ana Rita Godinho; Peter Heudtlass; Helena Luna Pais; Antonio Quintela; Ana Paula Martins;
PUBLISHED: 2020, SOURCE: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, VOLUME: 146, ISSUE: 5
INDEXED IN: Scopus WOS
2
TITLE: Using over-the-counter medication sales and the moving epidemic method for flu surveillance in Portugal (2016-2020)  Full Text
AUTHORS: Peter Heudtlass; Nuno Rodrigues; Antonio T Rodrigues; Ruben Pereira; Zilda Mendes;
PUBLISHED: 2020, SOURCE: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, VOLUME: 29
INDEXED IN: WOS
3
TITLE: Patient-reported outcomes and health-related quality of life for cetuximab versus bevacizumab in metastatic colorectal cancer: a prospective cohort study  Full Text
AUTHORS: Rui Pedro Marques; Peter Heudtlass; Helena Luna Pais; Antonio Quintela; Ana Paula Martins;
PUBLISHED: 2019, SOURCE: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, VOLUME: 145, ISSUE: 7
INDEXED IN: Scopus WOS
4
TITLE: A Bayesian hierarchical model for mortality data from cluster-sampling household surveys in humanitarian crises
AUTHORS: Peter Heudtlass; Debarati Guha Sapir; Niko Speybroeck;
PUBLISHED: 2018, SOURCE: INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, VOLUME: 47, ISSUE: 4
INDEXED IN: Scopus WOS

Um espaço para investigadores e suas instituições

Useful Links

Get Help

© 2024 CRACS & Inesc TEC - All Rights Reserved Privacy Policy | Terms of Service